INShore Phase 3 Study of Obinutuzumab vs. Mycophenolate Mofetil in Childhood-Onset Idiopathic Nephrotic Syndrome: Post Hoc Analysis Assessing the Effect of Prior Rituximab Use (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0941; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; P3 | "Conclusion Despite the imbalance of prior RTX use with a higher proportion in the OBI arm, there was no impact on the primary efficacy outcome in either arm at Week 52. The likelihood of achieving SCR with OBI was high and comparable in pts with and without prior RTX use."
Clinical • P3 data • Retrospective data • Glomerulonephritis • Nephrology • Renal Disease
|
|
Larry A. Greenbaum; Julien Hogan; Kenneth V. Lieberman; Kandai Nozu; Malgorzata Mizerska-wasiak; Clotilde Druck Garcia; Andrea Angeletti; Jie Ding; Xiaoyan Han; Sijing Li; Franz Schaefer; Patricia B. Lehane
|